Further scare mongering as the close of offer gets closer.Next we'll see a write down of resource and reserve ounces, but will have to do that soon with the offer closing Monday.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%